23 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
the independence of its research department and personnel. As a result, Ladenburg’s research analysts may hold views, make statements or investment
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
have the effect of delaying or preventing changes in control of the Company.
Director Independence
The Board has determined that Herb Cross, Jakob … has with the Company and all other facts and circumstances that the Board deems relevant in determining their independence, including the beneficial
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
Independence
The Board has determined that Herb Cross, Jakob Dupont, Meenu Karson, Gordon Ringold, Scott Smith, Samuel Wertheimer and Dan Zabrowski, do … in determining their independence, including the beneficial ownership of the Company’s capital stock by each non-employee director, and the transactions
POS AM
APGN
Apexigen Inc
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
of the Company’s directors may have the effect of delaying or preventing changes in control of the Company.
Director Independence
The Board has … that each non-employee director has with the Company and all other facts and circumstances that the Board deems relevant in determining their independence
POS AM
APGN
Apexigen Inc
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
in control of the Company.
Director Independence
The Board has determined that Herb Cross, Jakob Dupont, Meenu Karson, Gordon Ringold, Scott Smith … and circumstances that the Board deems relevant in determining their independence, including the beneficial ownership of the Company’s capital stock by each non
424B3
mquvhev ccr
9 Sep 22
Prospectus supplement
4:40pm
424B3
3hzbstnxrqc7eibrwjx9
9 Sep 22
Prospectus supplement
4:38pm
8-K
EX-3.2
k4h ezx8fo
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
S-4
2eqker9p9w7w tdv2s
8 Apr 22
Registration of securities issued in business combination transactions
6:37pm
10-K
qzbjclr pljb
7 Apr 22
Annual report
5:13pm
DEF 14A
ioxyqsbizd 17q30h
28 Mar 22
Definitive proxy
5:30pm
PRE 14A
3sgbn9i4nvsk
18 Mar 22
Preliminary proxy
5:21pm
424B4
fl1qcs0da99 ifizx8wt
29 Jan 21
Prospectus supplement with pricing info
10:01am